AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014
Jul 3, 2014
30583_dirs_2014-07-03_5a485200-3a69-46f2-a9c9-4e45a311b135.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-07-02
Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-02 | Common Stock | S | 2229 | $64.00 | Disposed | 70905 | Direct |
Footnotes
F1: Transaction made pursuant to a Rule 1b5-1 plan executed on December 9, 2013
F2: All shares sold at the same price
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19